These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 24705730

  • 1. Risk factors for incident major depressive disorder in children and adolescents with attention-deficit/hyperactivity disorder.
    Jerrell JM, McIntyre RS, Park YM.
    Eur Child Adolesc Psychiatry; 2015 Jan; 24(1):65-73. PubMed ID: 24705730
    [Abstract] [Full Text] [Related]

  • 2. Correlates of incident bipolar disorder in children and adolescents diagnosed with attention-deficit/hyperactivity disorder.
    Jerrell JM, McIntyre RS, Park YM.
    J Clin Psychiatry; 2014 Nov; 75(11):e1278-83. PubMed ID: 25470092
    [Abstract] [Full Text] [Related]

  • 3. Factors Associated With Musculoskeletal Injuries in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Guy JA, Knight LM, Wang Y, Jerrell JM.
    Prim Care Companion CNS Disord; 2016 Nov; 18(3):. PubMed ID: 27733957
    [Abstract] [Full Text] [Related]

  • 4. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF, Miller A, Fine S.
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [Abstract] [Full Text] [Related]

  • 5. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
    Sultan RS, Wang S, Crystal S, Olfson M.
    JAMA Netw Open; 2019 Jul 03; 2(7):e197850. PubMed ID: 31348506
    [Abstract] [Full Text] [Related]

  • 6. The role of comorbid major depressive disorder in the clinical presentation of adult ADHD.
    Fischer AG, Bau CH, Grevet EH, Salgado CA, Victor MM, Kalil KL, Sousa NO, Garcia CR, Belmonte-de-Abreu P.
    J Psychiatr Res; 2007 Dec 03; 41(12):991-6. PubMed ID: 17098256
    [Abstract] [Full Text] [Related]

  • 7. Attention-deficit/hyperactivity disorder in adolescence predicts onset of major depressive disorder through early adulthood.
    Meinzer MC, Lewinsohn PM, Pettit JW, Seeley JR, Gau JM, Chronis-Tuscano A, Waxmonsky JG.
    Depress Anxiety; 2013 Jun 03; 30(6):546-53. PubMed ID: 23424020
    [Abstract] [Full Text] [Related]

  • 8. [Comparing the comorbidity of attention-deficit/hyperactivity disorder in childhood and adolescence].
    Keresztény A, Dallos G, Miklósi M, Róka A, Gádoros J, Balázs J.
    Psychiatr Hung; 2012 Jun 03; 27(3):165-73. PubMed ID: 22781541
    [Abstract] [Full Text] [Related]

  • 9. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Dittmann RW, Schacht A, Helsberg K, Schneider-Fresenius C, Lehmann M, Lehmkuhl G, Wehmeier PM.
    J Child Adolesc Psychopharmacol; 2011 Apr 03; 21(2):97-110. PubMed ID: 21488751
    [Abstract] [Full Text] [Related]

  • 10. Does oppositional defiant disorder have temperament and psychopathological profiles independent of attention deficit/hyperactivity disorder?
    Kim HW, Cho SC, Kim BN, Kim JW, Shin MS, Yeo JY.
    Compr Psychiatry; 2010 Apr 03; 51(4):412-8. PubMed ID: 20579516
    [Abstract] [Full Text] [Related]

  • 11. Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder.
    Hazell P, Zhang S, Wolańczyk T, Barton J, Johnson M, Zuddas A, Danckaerts M, Ladikos A, Benn D, Yoran-Hegesh R, Zeiner P, Michelson D.
    Eur Child Adolesc Psychiatry; 2006 Mar 03; 15(2):105-10. PubMed ID: 16523251
    [Abstract] [Full Text] [Related]

  • 12. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder.
    Pliszka SR.
    Child Adolesc Psychiatr Clin N Am; 2000 Jul 03; 9(3):525-40, vii. PubMed ID: 10944655
    [Abstract] [Full Text] [Related]

  • 13. Stimulant and atypical antipsychotic medications for children placed in foster homes.
    Linares LO, Martinez-Martin N, Castellanos FX.
    PLoS One; 2013 Jul 03; 8(1):e54152. PubMed ID: 23326588
    [Abstract] [Full Text] [Related]

  • 14. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
    Pringsheim T, Hirsch L, Gardner D, Gorman DA.
    Can J Psychiatry; 2015 Feb 03; 60(2):42-51. PubMed ID: 25886655
    [Abstract] [Full Text] [Related]

  • 15. Comorbidity of disruptive behavioral disorders and attention-deficit hyperactivity disorder--indicator of severity in problematic behavior?
    Nordström T, Ebeling H, Hurtig T, Rodriguez A, Savolainen J, Moilanen I, Taanila A.
    Nord J Psychiatry; 2013 Aug 03; 67(4):240-8. PubMed ID: 23126481
    [Abstract] [Full Text] [Related]

  • 16. The longitudinal course of comorbid oppositional defiant disorder in girls with attention-deficit/hyperactivity disorder: findings from a controlled 5-year prospective longitudinal follow-up study.
    Biederman J, Petty CR, Monuteaux MC, Mick E, Parcell T, Westerberg D, Faraone SV.
    J Dev Behav Pediatr; 2008 Dec 03; 29(6):501-7. PubMed ID: 19077845
    [Abstract] [Full Text] [Related]

  • 17. Impact of Drug Adherence on Oppositional Defiant Disorder and Conduct Disorder Among Patients With Attention-Deficit/Hyperactivity Disorder.
    Wang LJ, Lee SY, Chou MC, Yang KC, Lee TL, Shyu YC.
    J Clin Psychiatry; 2018 Aug 28; 79(5):. PubMed ID: 30192445
    [Abstract] [Full Text] [Related]

  • 18. Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management.
    Pliszka SR.
    Paediatr Drugs; 2003 Aug 28; 5(11):741-50. PubMed ID: 14580223
    [Abstract] [Full Text] [Related]

  • 19. Higher risk of developing mood disorders among adolescents with comorbidity of attention deficit hyperactivity disorder and disruptive behavior disorder: a nationwide prospective study.
    Chen MH, Su TP, Chen YS, Hsu JW, Huang KL, Chang WH, Chen TJ, Bai YM.
    J Psychiatr Res; 2013 Aug 28; 47(8):1019-23. PubMed ID: 23643104
    [Abstract] [Full Text] [Related]

  • 20. Cortisol response to acute psychosocial stress in ADHD compared to conduct disorder and major depressive disorder: A systematic review.
    Bernhard A, Mayer JS, Fann N, Freitag CM.
    Neurosci Biobehav Rev; 2021 Aug 28; 127():899-916. PubMed ID: 34089765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.